中国医院用药评价与分析
中國醫院用藥評價與分析
중국의원용약평개여분석
Evaluation and Analysis of Drug-Use in Hospitals of China
2015年
8期
1091-1093
,共3页
药品不良反应%回顾性分析%合理用药
藥品不良反應%迴顧性分析%閤理用藥
약품불량반응%회고성분석%합리용약
Adverse drug reaction%Retrospective analysis%Rational use of drugs
目的:了解安徽省第二人民医院(以下简称"我院")药品不良反应( adverse drug reaction,ADR)发生的特点与规律,为减少ADR的发生提供参考. 方法:采用回顾性调查方法,对我院2013年1月-2014年12月上报的172例ADR报告进行分析. 结果:172例ADR中,男女患者分别为93、79例;≥60岁患者80例(占46. 51%);静脉给药引发的ADR为160例(占93. 02%);抗感染药引发的ADR为45例(26. 16%);ADR的临床表现主要为皮肤及其附件损害,共56例(32. 56%). 结论:临床应重视ADR的监测与上报工作,规范药品的合理使用,减少ADR的发生.
目的:瞭解安徽省第二人民醫院(以下簡稱"我院")藥品不良反應( adverse drug reaction,ADR)髮生的特點與規律,為減少ADR的髮生提供參攷. 方法:採用迴顧性調查方法,對我院2013年1月-2014年12月上報的172例ADR報告進行分析. 結果:172例ADR中,男女患者分彆為93、79例;≥60歲患者80例(佔46. 51%);靜脈給藥引髮的ADR為160例(佔93. 02%);抗感染藥引髮的ADR為45例(26. 16%);ADR的臨床錶現主要為皮膚及其附件損害,共56例(32. 56%). 結論:臨床應重視ADR的鑑測與上報工作,規範藥品的閤理使用,減少ADR的髮生.
목적:료해안휘성제이인민의원(이하간칭"아원")약품불량반응( adverse drug reaction,ADR)발생적특점여규률,위감소ADR적발생제공삼고. 방법:채용회고성조사방법,대아원2013년1월-2014년12월상보적172례ADR보고진행분석. 결과:172례ADR중,남녀환자분별위93、79례;≥60세환자80례(점46. 51%);정맥급약인발적ADR위160례(점93. 02%);항감염약인발적ADR위45례(26. 16%);ADR적림상표현주요위피부급기부건손해,공56례(32. 56%). 결론:림상응중시ADR적감측여상보공작,규범약품적합리사용,감소ADR적발생.
OBJECTIVE:To investigate the regulations and characteristics of the adverse drug reaction( ADR) in the Second People's Hospital of Anhui Province ( hereinafter referred to as "our hospital") , and to provide reference for the reduction of the occurrence of ADR. METHODS:Retrospective investigation was adopted, a total of 172 cases of ADR reports collected in our hospital from Jan. 2013 to Dec. 2014 were statistically analyzed. RESULTS:Of the total 172 cases, 93 cases were male, 79 cases were female. There were 80 cases of senile patients aged above 60 years old, accounting for 46. 51%;there were 160 cases of ADR induced by intravenous dripping, accounting for 93. 02%;most ADR were induced by antibiotics drugs, accounting for 26. 16%; the most common clinical manifestations were the damage of skin and its appendants, totally with 56 cases, accounting for 32. 56%. CONCLUSIONS:The clinic should attach more importance to ADR monitoring and report, regulate the rational use of drugs so as to reduce the incidence of ADR.
